HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Histopathology of carcinomas of the liver in mice fed perthane.

Abstract
B6C3F1 female mice fed an average dose of 3,000 ppm of perthane for 2 years developed a highly significant incidence of hepatocellular carcinomas of the liver. Male mice fed 2,500 ppm perthane had a slight increase of carcinoma of the liver. Some of the carcinomas were well-differentiated; however, most were poorly differentiated or undifferentiated. Perthane-treated mice also had well and poorly differentiated cholangiocarcinomas and carcinosarcomas, neoplasms not seen in control mice.
AuthorsM D Reuber
JournalTumori (Tumori) Vol. 66 Issue 3 Pg. 277-83 (Jun 30 1980) ISSN: 0300-8916 [Print] United States
PMID6255646 (Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • perthane
  • Dichlorodiphenyldichloroethane
Topics
  • Adenoma, Bile Duct (chemically induced)
  • Animals
  • Body Weight (drug effects)
  • Dichlorodiphenyldichloroethane (analogs & derivatives, toxicity)
  • Female
  • Liver Neoplasms (chemically induced, pathology)
  • Liver Neoplasms, Experimental (chemically induced, pathology)
  • Male
  • Mice
  • Sex Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: